Characterisation of a K390R ITK kinase dead transgenic mouse--implications for ITK as a therapeutic target.
Deakin A, Duddy G, Wilson S, Harrison S, Latcham J, Fulleylove M, Fung S, Smith J, Pedrick M, McKevitt T, Felton L, Morley J, Quint D, Fattah D, Hayes B, Gough J, Solari R.
Deakin A, et al. Among authors: wilson s.
PLoS One. 2014 Sep 24;9(9):e107490. doi: 10.1371/journal.pone.0107490. eCollection 2014.
PLoS One. 2014.
PMID: 25250764
Free PMC article.